Presentation TCT 2016 TCT 313: Incidence and Predictors of Very Late Major Adverse Cardiac Events After Metallic Stents: A Patient-Level Pooled Analysis from Seventeen Randomized Trials Presenter: Serban Puricel, Clemens von Birgelen November 01, 2016
Presentation TCT 2016 TCT 312: Increased Cardiac Death and Stent Thrombosis in Chronic Obstructive Pulmonary Disease Patients Undergoing Percutaneous Coronary Intervention. An Analysis of the BASKET-PROVE I and II trials. Presenter: Serban Puricel, Clemens von Birgelen November 01, 2016
Presentation TCT 2016 TCT 401: Bioresorbable Scaffolds And Thrombosis: Insights From The GHOST-EU (Gauging coronary Healing with Bioresorbable Scaffolding Platforms in Europe) Registry Presenter: Serban Puricel, Clemens von Birgelen November 01, 2016
Presentation TCT 2016 TCT 402: Relationship Between Bioresorbable Scaffold Sizing and Scaffold Thrombosis: A Pooled Analysis of ABSORB Trials Presenter: Serban Puricel, Clemens von Birgelen November 01, 2016
News Industry News TCT 2016 Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures November 01, 2016
News Conference News TCT 2016 New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts Yael L. Maxwell October 31, 2016
News Conference News TCT 2016 EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease Michael O'Riordan October 31, 2016
News Conference News TCT 2016 Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI Yael L. Maxwell October 31, 2016
Presentation TCT 2016 Case Presentation: Evaluation and Management of Recurrent DES Restenosis Presenter: Fernando Alfonso, Stephan Windecker, Adnan K. Chhatriwalla October 30, 2016
Presentation TCT 2016 Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis? Presenter: Fernando Alfonso, Stephan Windecker, Ron Waksman October 30, 2016
Presentation TCT 2016 Prognosis and Treatment Options for DES Restenosis and Re-restenosis Presenter: Fernando Alfonso, Stephan Windecker October 30, 2016
News Conference News TCT 2016 BIONICS: Ridaforolimus-Eluting Stent Noninferior to Zotarolimus Stent at 1 Year TCT Daily Staff October 30, 2016
Presentation TCT 2016 Case Presentation: A Surprise in the Evaluation and Management of Stent Thrombosis Presenter: Fernando Alfonso, Stephan Windecker, Ehrin J. Armstrong October 30, 2016
Presentation TCT 2016 How to Evaluate and Treat the Patient With Metallic Stent Thrombosis: The Usual Suspects and Beyond Presenter: Fernando Alfonso, Stephan Windecker, Giulio G. Stefanini October 30, 2016
Presentation TCT 2016 Are All Stent Thromboses Prognostically Created Equal? Impact of Original Clinical Presentation, Stent Location and Thrombosis Timing Presenter: Fernando Alfonso, Stephan Windecker, Robert-Jan van Geuns October 30, 2016
Presentation TCT 2016 Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety? Presenter: Fernando Alfonso, Stephan Windecker, Giulio Guagliumi October 30, 2016
Presentation TCT 2016 OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications Presenter: Fernando Alfonso, Stephan Windecker, Stephen WL Lee October 30, 2016
Presentation TCT 2016 Is Acute or Late Acquired Malapposition By IVUS or OCT A Risk Factor for Stent Thrombosis? Presenter: Fernando Alfonso, Stephan Windecker, Gary S. Mintz October 30, 2016
Presentation TCT 2016 New Insights Into the Mechanisms and Patterns of in-stent Restenosis in BMS and DES Evaluated By IVUS and OCT (With Case Examples) Presenter: Fernando Alfonso, Stephan Windecker, Akiko Maehara October 30, 2016
Presentation TCT 2016 Vietnam Presents: A Case of Recurrent, Subacute Left Main Stent Thrombosis Presenter: Thomas Engstroem, Hyo-Soo Kim, Samer Mansour, Quang Ngoc Nguyen October 30, 2016